Andrew E. Aplin
- Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research 22
- Cell Biology top 0.5%
- Cellular Mechanics and Interactions 15
- Cancer Research top 1%
- Molecular Biology top 1%
- Melanoma and MAPK Pathways 38
- Ubiquitin and proteasome pathways 12
- Cell death mechanisms and regulation 10
- Oncology top 1%
- Cancer-related Molecular Pathways 13
-
- Ocular Oncology and Treatments 26
-
- Immunotherapy and Immune Responses 10
- Co-authors
- R. L. JulianoAlan K. HoweSuresh K. AlahariYongping ShaoDan A. ErkesEmad S. AlnemriCorey RogersEthan V. Abel
- Journals
- Cancer Research (14 papers)Molecular Cancer Research (10 papers)Journal of Biological Chemistry (10 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Andrew E. Aplin
116 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Immunology and Allergy 1.3k
- Cell Biology 1.5k
- Cancer Research 1.2k
- Molecular Biology 5.4k
- Oncology 1.9k
Countries citing papers authored by Andrew E. Aplin
This map shows the geographic impact of Andrew E. Aplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Aplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Aplin more than expected).
Fields of papers citing papers by Andrew E. Aplin
This network shows the impact of papers produced by Andrew E. Aplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Aplin. The network helps show where Andrew E. Aplin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew E. Aplin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2023 | 16 | |
| 3 | 2022 | 22 | |
| 4 | 2022 | 15 | |
| 5 | 2019 | 34 | |
| 6 | 2019 | 16 | |
| 7 | Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosisbreakdown → | 2019 | 341 |
| 8 | 2018 | 13 | |
| 9 | 2018 | 69 | |
| 10 | 2017 | 54 | |
| 11 | 2017 | 20 | |
| 12 | 2015 | 53 | |
| 13 | 2014 | 45 | |
| 14 | 2014 | 23 | |
| 15 | 2012 | 124 | |
| 16 | 2010 | 69 | |
| 17 | 2010 | 151 | |
| 18 | 2010 | 53 | |
| 19 | 2009 | 108 | |
| 20 | 2009 | 75 |
About Andrew E. Aplin
Andrew E. Aplin is a scholar working on Immunology and Allergy, Ophthalmology and Cell Biology, having authored 121 papers that have together received 7.8k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (38 papers), Ocular Oncology and Treatments (26 papers), Cell Adhesion Molecules Research (22 papers), Cellular Mechanics and Interactions (15 papers), Cancer-related Molecular Pathways (13 papers), Ubiquitin and proteasome pathways (12 papers), Cell death mechanisms and regulation (10 papers) and Immunotherapy and Immune Responses (10 papers). The work is most often cited by research in Immunology and Allergy (1.3k citations), Cell Biology (1.5k citations) and Cancer Research (1.2k citations). Andrew E. Aplin has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include R. L. Juliano, Alan K. Howe, Suresh K. Alahari, Yongping Shao, Dan A. Erkes, Emad S. Alnemri, Corey Rogers, Ethan V. Abel, Teresa Fernandes‐Alnemri and Timothy J. Purwin. Their work appears in journals such as Cancer Research, Molecular Cancer Research, Journal of Biological Chemistry, Pigment Cell & Melanoma Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.